Grosso, A.A.; Campi, R.; Di Maida, F.; Pecoraro, A.; Conte, F.L.; Cangemi, V.; Catanzaro, R.; Kucuku, N.; Doumit, N.; Mari, A.;
et al. Impact of the COVID-19 Prioritization Recommendations on Pathological Stages of Urologic Malignancies: A Real-World Analysis at a High-Volume Referral Institution. J. Clin. Med. 2024, 13, 5992.
https://doi.org/10.3390/jcm13195992
AMA Style
Grosso AA, Campi R, Di Maida F, Pecoraro A, Conte FL, Cangemi V, Catanzaro R, Kucuku N, Doumit N, Mari A,
et al. Impact of the COVID-19 Prioritization Recommendations on Pathological Stages of Urologic Malignancies: A Real-World Analysis at a High-Volume Referral Institution. Journal of Clinical Medicine. 2024; 13(19):5992.
https://doi.org/10.3390/jcm13195992
Chicago/Turabian Style
Grosso, Antonio Andrea, Riccardo Campi, Fabrizio Di Maida, Alessio Pecoraro, Francesco Lupo Conte, Vincenzo Cangemi, Rossella Catanzaro, Neliana Kucuku, Nassima Doumit, Andrea Mari,
and et al. 2024. "Impact of the COVID-19 Prioritization Recommendations on Pathological Stages of Urologic Malignancies: A Real-World Analysis at a High-Volume Referral Institution" Journal of Clinical Medicine 13, no. 19: 5992.
https://doi.org/10.3390/jcm13195992
APA Style
Grosso, A. A., Campi, R., Di Maida, F., Pecoraro, A., Conte, F. L., Cangemi, V., Catanzaro, R., Kucuku, N., Doumit, N., Mari, A., Masieri, L., Serni, S., & Minervini, A.
(2024). Impact of the COVID-19 Prioritization Recommendations on Pathological Stages of Urologic Malignancies: A Real-World Analysis at a High-Volume Referral Institution. Journal of Clinical Medicine, 13(19), 5992.
https://doi.org/10.3390/jcm13195992
